<DOC>
	<DOCNO>NCT01335516</DOCNO>
	<brief_summary>Terlipressin effective safe treatment bleeding cause rupture oesophageal varix , life-threatening complication liver cirrhosis . Oesophageal varix abnormal dilatation vein occur low oesophagus , develop patient cirrhosis . Bleeding cause rupture varix life-threatening complication mortality 20-50 % . Such bleeding treat drug therapy and/or endoscopic ; endoscopic therapy consist flexible tube equip camera terminal end , allow visualize treat oesophageal varix . In study , investigator evaluate safety efficacy terlipressin - Glypressin 1 mg , powder solvent solution injection . The non-interventional observational study `` Follow-up Glypressin ( terlipressin ) clinical efficacy treatment bleed oesophageal varix '' aim demonstrate administration Glypressin ( terlipressin 1 mg ) control bleed patient .</brief_summary>
	<brief_title>Follow-up Glypressin ( Terlipressin ) Clinical Efficacy Treatment Bleeding Oesophageal Varices</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Varicose Veins</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Terlipressin</mesh_term>
	<mesh_term>Lypressin</mesh_term>
	<criteria>Eligible patient present important upper gastrointestinal bleeding , suspect diagnose liver cirrhosis , bleed oesophageal varix visualize endoscopically . ( An important upper gastrointestinal bleed one require least 2 units/24h transfuse blood ) . Septic shock Patients recent history coronary insufficiency Uncontrolled arterial hypertension Chronic respiratory failure Symptomatic arteritis Chronic renal failure Pregnant woman Hypersensitivity terlipressin Patients body weight 55 kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>